Introduction. Survival analysis is a subfield of statistics that deals with predicting the duration of time until a specific event occurs, such as the failure of a machine, occurrence of a disease, or death of a patient. Read more
Adverse drug reactions (ADRs) are unintended, harmful events attributed to the use of medicines. In modern healthcare, ADRs pose a significant challenge due to the complexity of therapeutics, an aging population, and rising multimorbidity. Read more
International efforts to eliminate HIV/AIDS by 2030 are failing high-risk populations, particularly people who inject drugs (PWID), who frequently have high HIV prevalence[1]. Read more
Background. Birth defects are complex developmental phenotypes affecting ~6% of births worldwide. Congenital heart disease (CHD), accounting for 1/6th of these defects is still not fully understood, with the role of inflammation and the contribution of inflammatory cells in disease progression still to be elucidated. Read more
This project aims to investigate rates of hospitalisations due to different causes among people with HIV on antiretroviral therapy, and how they differ by subgroups, for example, by gender or age. Read more
Heat shock response (HSR) is a universally existing essential phenomenon for all living organisms to survive sudden increases in environmental temperature that have pronounced damaging effects on important cellular structures and functions (1). Read more
In the adult brain, new neurons are continuously generated in the hippocampal dentate gyrus (DG). This neurogenesis process is highly regulated and consists of cell proliferation, neuronal differentiation, neuronal maturation and survival. Read more
Background. Pancreatic cancer is the deadliest of the common cancers. Five-year survival remains low at 10%. Sadly for 80% of patients, by the time their cancer is diagnosed it has spread to distant organs making them ineligible for potentially curative surgery. Read more
More than 140 children with cancer die in Australia each year due to the occurrence of resistance to traditional chemotherapy. To improve overall survival rates for high-risk paediatric cancer patients, the Children’s Cancer Institute initiated the Zero Childhood Cancer national personalised medicine trial (PRISM). Read more
Fungal diseases affect approximately 1.2 billion individuals worldwide with at least 1.5 million deaths each year. The emergence of resistant strains made clinical treatment failures more frequent. Read more
Gastric Cancer is the fifth most common malignancy in the world and third leading cause of death. It has claimed 865,000 lives worldwide in 2017, 12 lives/day in the UK (2016-2018). Read more
Commercial partner: Alpha Laboratories Ltd. Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. In the UK, around 43,000 new CRC cases are recorded annually, and its comparatively high incidence and mortality represent a considerable public health burden. Read more
Background. Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in humans. There is a high unmet medical need to develop new therapies for the treatment of this disease. Read more
Common heart diseases such as heart failure (HF) and coronary heart disease (CHD) are characterized by cardiomyocyte loss due to necrosis and apoptosis. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Create your FindAPhD account and sign up to our newsletter:
Find out about funding opportunities and application tips
Receive weekly advice, student stories and the latest PhD news
Hear about our upcoming study fairs
Save your favourite projects, track enquiries and get personalised subject updates
Create your myFindAPhD account to add this PhD to your shortlist to register for this event to receive updates on upcoming events
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Continue with Facebook
Looking to list your PhD opportunities? Log in here.